Spiriva Respimat tiotropium bromide: Phase III data

By WIR Staff | Mar 2, 2015 | 8:00 AM GMT

The MezzoTinA-asthma trials are part of the Phase III UniTinA-asthma program, which is evaluating Spiriva Respimat in over 6,000 patients with different asthma severities who remain symptomatic on ICS. The product is